Transposon Therapeutics’ TPN-101 to be studied for extending healthy aging
Transposon Therapeutics’ TPN-101 to be Studied for Extending Healthy Aging
BioSpace - March 4, 2026
UTMB will collaborate on the ARPA-H PROSPR program to support the development of TPN-101 to slow aging and help people stay healthy longer.